SynthesisPain2026
Chronic widespread pain and the risk of cardiovascular disease-a systematic review and meta-analysis.
Synthesis in Pain, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
abstractPrevious research indicates that individuals with chronic widespread pain (CWP) have an excess risk of cardiovascular disease. Given the high global prevalence of CWP, this association may have substantial public health implications. Our objective was to summarise the current evidence on the association between CWP and incident cardiovascular disease in a systematic review and meta-analysis. We searched major databases (MEDLINE, Embase, Web of Science, and Cochrane) and included studies based on predefined eligibility criteria. We identified 18 studies reporting associations between CWP (n = 80,021) and atherosclerotic diseases or cardiovascular mortality (n events = 33,799). In the meta-analysis, we removed studies that analysed identical outcomes in the same population. Individuals with CWP had an almost doubled risk of atherosclerotic diseases, RR 1.94 (95% confidence interval [CI]: 1.56-2.41), and for cardiovascular mortality, the RR was 1.61 (95% CI: 1.24-2.08) in the minimally adjusted models. In the maximally adjusted model, the RR for atherosclerotic diseases was 1.53 (95% CI: 1.27-1.86) vs RR 1.12 (95% CI: 0.93-1.34) for cardiovascular mortality. The heterogeneity was high and potential publication bias was indicated for the mortality analysis. This meta-analysis, although based on relatively few studies with high heterogeneity, shows that CWP is consistently associated with incident atherosclerotic disease. Evidence for an association with cardiovascular mortality is less conclusive. Individuals with CWP may represent an underrecognized high-risk group for atherosclerotic diseases that could benefit from proactive cardiovascular risk assessment and intensified prevention. Further high-quality studies are warranted to confirm the strength and causality of the association.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.